InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Hall Brett Matthew, Directeur Scientifique. Officer active across 1 companies, notably Immuneering Corp. Cumulatively, 6 filings have been recorded. Total volume traded: €17k. The latest transaction was disclosed on 25 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€9,3572,551 shares@ €3.66810.0028% mcap55.4% of flow
Class A Common Stock
SEC:0001415889-22-005796:0·
Ideal exit: 19 Feb 2023 (T+270)
€7,5301,050 shares@ €7.17150.0023% mcap44.6% of flow
Class A Common Stock
SEC:0001415889-22-003305:0·
Ideal exit: 18 Dec 2022 (T+270)
322,691 shares
Class A Common Stock
SEC:0001415889-21-006188·
322,691 shares
Class A Common Stock
SEC:0001415889-21-006188:0·
5,040 shares
Class A Common Stock
SEC:0001104659-21-099733·
5,040 shares
Class A Common Stock
SEC:0001104659-21-099733:0·
6 of 6 declarations
About Hall Brett Matthew
Brett Matthew Hall is the Chief Scientific Officer at Immuneering Corp. In this role, he is responsible for leading scientific research and product development. Hall plays a key role in innovation and advancing the company's therapeutic solutions. His scientific expertise is essential for supporting Immuneering's mission to provide advanced treatments.
